MED9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.69853020537403E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.48083800566701E-12 |
Normal-vs-Stage2 |
4.28070001667891E-09 |
Normal-vs-Stage3 |
1.62481139653892E-12 |
Normal-vs-Stage4 |
1.62703184258817E-12 |
Stage1-vs-Stage2 |
5.569800E-01 |
Stage1-vs-Stage3 |
6.25009999977166E-07 |
Stage1-vs-Stage4 |
2.300000E-03 |
Stage2-vs-Stage3 |
1.312230E-01 |
Stage2-vs-Stage4 |
2.487200E-01 |
Stage3-vs-Stage4 |
5.591000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.65101265992007E-12 |
Normal-vs-AfricanAmerican |
1.52649999973775E-07 |
Normal-vs-Asian |
3.599200E-03 |
Caucasian-vs-AfricanAmerican |
8.143200E-03 |
Caucasian-vs-Asian |
8.628200E-01 |
AfricanAmerican-vs-Asian |
3.728200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.01980662698043E-14 |
Normal-vs-Female |
2.42206255052224E-12 |
Male-vs-Female |
1.083560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.96999999996828E-07 |
Normal-vs-Age(41-60Yrs) |
2.00095495728192E-12 |
Normal-vs-Age(61-80Yrs) |
3.38618022510673E-14 |
Normal-vs-Age(81-100Yrs) |
2.18840001675602E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.535600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.443000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.747400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.252000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.294200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.691800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.798900E-04 |
Normal-vs-Grade 2 |
4.07229805432507E-12 |
Normal-vs-Grade 3 |
1.63147273468667E-12 |
Normal-vs-Grade 4 |
<1E-12 |
Grade 1-vs-Grade 2 |
4.090000E-02 |
Grade 1-vs-Grade 3 |
1.724930E-03 |
Grade 1-vs-Grade 4 |
4.696099999979E-07 |
Grade 2-vs-Grade 3 |
4.084800E-03 |
Grade 2-vs-Grade 4 |
9.93730000509174E-08 |
Grade 3-vs-Grade 4 |
5.361100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.30737651207846E-12 |
Normal-vs-ccB subtype |
1.62470037423645E-12 |
ccA subtype-vs-ccB subtype |
1.538190E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.82787118774286E-12 |
Normal-vs-N1 |
5.62759838729221E-11 |
N0-vs-N1 |
3.781800E-01 |
|
|